The female mortality from cvd, cancer, diabetes or crd between exact ages 30 and 70 in Nicaragua is currently 13.4%, a decrease of 0.1% (-0.7%) compared to 2018.
Female mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70 in Nicaragua
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2019
Points:
13,760
Measure:
%
Similar regions to Nicaragua
Female CVD, cancer, diabetes or CRD
More indicators for Nicaragua
Out-of-pocket expenditure PPP per capita
intl dollar185
+intl dollar32
(2021)
Newborns protected against tetanus
92%
0%
(2022)
Female wasting in children
2.1%
+0.7%
(2012)
Birth registration
84.7%
+3.7%
(2012)
Female prevalence of HIV
0.1%
0%
(2022)
Contraceptive modern method prevalence
77.4%
+7.6%
(2012)
Nicaragua Female CVD, cancer, diabetes or CRD between 2000 and 2019
Period | Female CVD, cancer, diabetes or CRD | Change |
---|---|---|
2019 | 13.4% | -0.1% |
2018 | 13.5% | -0.1% |
2017 | 13.6% | -0.1% |
2016 | 13.7% | +0.5% |
2015 | 13.2% | -0.9% |
2014 | 14.1% | +0.6% |
2013 | 13.5% | -0.5% |
2012 | 14% | +0.1% |
2011 | 13.9% | -0.1% |
2010 | 14% | -0.2% |
2009 | 14.2% | -0.1% |
2008 | 14.3% | +0.3% |
2007 | 14% | +0.8% |
2006 | 13.2% | -1.4% |
2005 | 14.6% | +0.1% |
2004 | 14.5% | +0.3% |
2003 | 14.2% | -0.6% |
2002 | 14.8% | +0.5% |
2001 | 14.3% | +0.3% |
2000 | 14% |